Dix-sept ans d’hémovigilance en France : bilan, perspectives

Transfusion of blood components is considered safer, but it took years to reach this level. One of the most effective ways to make blood transfusion a safer practice is hemovigilance, which provides important data, including the history of feared transfusion reactions. In recent years in Brazil, there has been an improvement in the reporting of transfusion reactions, however due to the great diversity of hematology services, there are still transfusion reactions. The aims of this study were described the main types of transfusion reactions, as well as to evaluate the underreporting importance of transfusion occurrences of hemotherapy services in Brazil.

show abstract

“…The main goal in developing hemovigilance programs is to increase the number of notifications of transfusion adverse events [9][10][11][12].…”

Section: Discussionmentioning

confidence: 99%

Transfusion reaction and hemovigilance: An imperative discussion in Brazilian hemotherapy services

Santos

Alzamora²,

Teles³

et al. 2017

int arch med

View full text Add to dashboard Cite

show abstract

“…Through the evolution of haemovigilance definition in different periods, we can find its scope and breadth as well as its important contribution in ensuring the safety of blood transfusion. The first French official definition of haemovigilance dates back to 1994 , as ‘a component of transfusion safety’, and it is consisted of three contents for each unit of blood product and component prepared as follows: (1) the alert of any unexpected or unwanted effects related to or likely to be related to the therapeutic use of this product; (2) the collection, preservation and accessibility of information of the blood sample, the collection, the use, as well as the effects mentioned above; (3) the evaluation and the use of such information to prevent the occurrence of any unexpected or unwanted effects resulting from the therapeutic use of blood products and components. This definition indicates that its primary aim is to insure the monitoring of blood transfusion, to collect and assess data on all side‐effects related to blood transfusion from the collection of blood and to the use of a blood product and of preventing their occurrence, so as to increase the safety and quality of the entire transfusion process.…”

Section: Haemovigilance Evolutionmentioning

confidence: 99%

“…The ex‐President of IHN, Prof. Dr René R. P. De Vries, summarized 10 results and conclusions of haemovigilance practice in 2011 on the occasion of the Vox Sanguinis's 100th issue . He pointed out that ‘Haemovigilance systems have shown that blood transfusion is relatively safe compared with the use of medicinal drugs and that at least in Europe blood components have reached a high safety standard’, that ‘The type of organization of a haemovigilance system is of relative value, and different systems may have the same outcome’, that ‘Well‐functioning haemovigilance systems have not only indicated how safety should be improved, but also documented the success of various measures’, that ‘Haemovigilance systems and officers may be used to improve the quality of aspects of blood transfusion other than safety, such as appropriate use’, that ‘Haemovigilance systems will be of benefit also for vigilance and surveillance of the treatment with other human products such as cells, tissues and organs etc., it turns out that haemovigilance has made great achievements to improve quality and safety of entire transfusion process.…”

Section: Achievements and Challengesmentioning

confidence: 99%

The haemovigilance: the best quality management system of the transfusion chain?

Liang

et al. 2018

ISBT Science Series

View full text Add to dashboard Cite

Background and Objectives Haemovigilance is an integral part of blood safety worldwide. Many haemovigilance systems are already in place or are developing, and national or regional haemovigilance systems have been implemented in several countries. In 2016, the WHO Global Database on Blood Safety reported that national haemovigilance system had been established in 70 countries, among which 38 countries were members of the International Haemovigilance Network by the end of August 2017. In this review, we retrospect the development and current status of haemovigilance to outline its function in transfusion chain. Materials and Methods Through contrasting the evolution of haemovigilance definition in different periods, by analysing its scope and breadth, and with the illustrating its achievements and challenges, we retrospect the development and current status of haemovigilance to outline its function in transfusion chain. Results Haemovigilance is becoming an important aspect of transfusion medicine,could be used as quality indicator for monitoring the blood transfusion safety, contribute significantly to evidence‐based transfusion medicine and results in improved policies, procedures and practices in the blood transfusion chain. Conclusions The scope of haemovigilance may cover the whole transfusion chain, from collection of blood and its components to follow‐up of recipients. Haemovigilance is an essential component of quality management in a blood system and haemovigilance is the best quality management system of the transfusion chain.

show abstract

“…In 1994, the French Blood Agency started setting a network of healthcare professionals with specific roles to signal, notify and review transfusion-related adverse reactions [3]. This monitoring system became the first national Haemovigilance system worldwide.…”

Section: Introductionmentioning

confidence: 99%

HaemoKBS: A knowledge-based system for real-time, continuous categorisation of adverse reactions in blood recipients

Ramoa

Condeço²,

Fdez-Riverola

et al. 2021

Neurocomputing

View full text Add to dashboard Cite

This work introduces HaemoKBS, a novel Haemovigilance decision support system for adverse reactions in blood recipients. Machine learning inference and rule-based reasoning were applied to build the underlying decision support models, namely to automatically extract evidence from different types of data included in hospital notifications and incorporate a priori expert knowledge. The ultimate aim is to dynamically learn and improve the reasoning abilities of the system and thus, be able to provide educated recommendations to hospital notifiers along with understandable explanations on the acquired knowledge. Experiments over the records of the Portuguese National Haemovigilance System from the last 10 years demonstrate the practical usefulness of HaemoKBS, which will contribute to a better depiction of the adverse reactions and to flag any incomplete notification enforcing data quality.

show abstract

Dix-sept ans d’hémovigilance en France : bilan, perspectives

Cited by 16 publications

References 11 publications

Transfusion reaction and hemovigilance: An imperative discussion in Brazilian hemotherapy services

Transfusion reaction and hemovigilance: An imperative discussion in Brazilian hemotherapy services

The haemovigilance: the best quality management system of the transfusion chain?

HaemoKBS: A knowledge-based system for real-time, continuous categorisation of adverse reactions in blood recipients

Contact Info

Product

Resources

About